Podstawa prawna: art. 56. 1. 2 of Act on Public Offering.

Sopharma AD notifies that for January 2021 the Company recorded a increase in sales of 10% compared to the same month of 2020, incl. 20% increase in domestic sales and 7% increase in export sales.

Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1

kom espi zdz